TY - JOUR
T1 - The protective impact of myricetin against PM2.5-induced cellular apoptosis by inhibiting endoplasmic reticulum stress
AU - Herath, Herath Mudiyanselage Udari Lakmini
AU - Park, Musun
AU - Piao, Mei Jing
AU - Kang, Kyoung Ah
AU - Fernando, Pincha Devage Sameera Madushan
AU - Senavirathna, Herath Mudiyanselage Maheshika Madhuwanthi
AU - Kim, Hee Sun
AU - Chae, Sungwook
AU - Kim, Young Ree
AU - Hyun, Jin Won
N1 - Publisher Copyright:
© 2024
PY - 2025/4
Y1 - 2025/4
N2 - Particulate matter 2.5 (PM2.5) exposure is responsible for skin inflammation, aging, and disruption of skin homeostasis. The objective of this investigation was to assess the potential of myricetin in protecting against skin damage caused by PM2.5. Human keratinocytes (HaCaT) were pretreated with myricetin and subsequently exposed to PM2.5. Cell viability, reactive oxygen species (ROS) generation, oxidized cellular components, mitochondrial damage, cellular apoptosis, and endoplasmic reticulum (ER) stress were assessed. A mitogen-activated protein kinase (MAPK) signaling network was constructed, and the action site of myricetin was explored through docking analysis. PM2.5 induced oxidative stress, resulting in DNA damage, lipid peroxidation, protein carbonylation, and cellular apoptosis. Myricetin counteracted these effects by reducing the PM2.5-induced ROS levels. Additionally, myricetin mitigated the PM2.5-induced cytochrome c release into the cytoplasm and caspase activation, thereby ameliorating cellular apoptosis. Myricetin reduced PM2.5-induced cytosolic Ca2+ level and ER-related signaling molecules. Furthermore, myricetin inhibited cellular cytotoxicity by downregulating the MAPK signaling pathway. Docking and network analyses identified 12 major MAPK proteins targeted by myricetin, and these proteins primarily affected the classical MAPK pathway. These findings suggest that myricetin mitigates skin impairments caused by PM2.5 exposure by reducing ROS, mitochondrial damage, ER stress, and apoptosis via downregulating the MAPK signaling pathway.
AB - Particulate matter 2.5 (PM2.5) exposure is responsible for skin inflammation, aging, and disruption of skin homeostasis. The objective of this investigation was to assess the potential of myricetin in protecting against skin damage caused by PM2.5. Human keratinocytes (HaCaT) were pretreated with myricetin and subsequently exposed to PM2.5. Cell viability, reactive oxygen species (ROS) generation, oxidized cellular components, mitochondrial damage, cellular apoptosis, and endoplasmic reticulum (ER) stress were assessed. A mitogen-activated protein kinase (MAPK) signaling network was constructed, and the action site of myricetin was explored through docking analysis. PM2.5 induced oxidative stress, resulting in DNA damage, lipid peroxidation, protein carbonylation, and cellular apoptosis. Myricetin counteracted these effects by reducing the PM2.5-induced ROS levels. Additionally, myricetin mitigated the PM2.5-induced cytochrome c release into the cytoplasm and caspase activation, thereby ameliorating cellular apoptosis. Myricetin reduced PM2.5-induced cytosolic Ca2+ level and ER-related signaling molecules. Furthermore, myricetin inhibited cellular cytotoxicity by downregulating the MAPK signaling pathway. Docking and network analyses identified 12 major MAPK proteins targeted by myricetin, and these proteins primarily affected the classical MAPK pathway. These findings suggest that myricetin mitigates skin impairments caused by PM2.5 exposure by reducing ROS, mitochondrial damage, ER stress, and apoptosis via downregulating the MAPK signaling pathway.
KW - Apoptosis
KW - ER stress
KW - Myricetin
KW - PM
KW - ROS
UR - https://www.scopus.com/pages/publications/85213207997
U2 - 10.1016/j.tiv.2024.106002
DO - 10.1016/j.tiv.2024.106002
M3 - Article
C2 - 39719177
AN - SCOPUS:85213207997
SN - 0887-2333
VL - 104
JO - Toxicology in Vitro
JF - Toxicology in Vitro
M1 - 106002
ER -